Answers are grounded in this paper and cite their sources.
These results from a population of healthy volunteers support once/day dosing of tedizolid phosphate 200 mg with both the oral and IV formulations, without the need for dose adjustment when switching administration routes.
No takes yet. Share an insight, caveat, or question.
Flanagan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: